Form 8-K - Current report:
SEC Accession No. 0001104659-14-042933
Filing Date
2014-05-30
Accepted
2014-05-30 16:48:10
Documents
2
Period of Report
2014-05-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a14-14347_18k.htm 8-K 25430
2 EX-10.1 a14-14347_1ex10d1.htm EX-10.1 54884
  Complete submission text file 0001104659-14-042933.txt   81708
Mailing Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139
Business Address ONE KENDALL SQUARE BUILDING 1400 EAST 4TH FLOOR CAMBRIDGE MA 02139 617-863-5524
INVIVO THERAPEUTICS HOLDINGS CORP. (Filer) CIK: 0001292519 (see all company filings)

EIN.: 000000000 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-52089 | Film No.: 14880933
SIC: 3841 Surgical & Medical Instruments & Apparatus